Navigation Links
Hospira's Precedex(R) Phase IV Study Published in the Journal of the American Medical Association
Date:2/2/2009

ent of patients in both intensive care unit and procedural sedation include hypotension, bradycardia, and dry mouth.

About Hospira

Hospira, Inc. is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness(TM). As the world leader in specialty generic injectable pharmaceuticals, Hospira offers one of the broadest portfolios of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions. Through its products, Hospira helps improve the safety, cost and productivity of patient care. The company is headquartered in Lake Forest, Ill., and has more than 14,000 employees. Learn more at www.hospira.com.

    (1) Society of Critical Care Medicine. Critical Care Statistics in the
        United States. Retrieved January 2, 2009. Web site:
       http://sccmcms.sccm.org/NR/rdonlyres/1FCD55C6-71B0-48CA-B652-
        31EBB61DD202/504/WebStatisticsPamphletFinalJune07.pdf

    (2) Dasta, Joseph F., McLaughlin, Trent P., et al. Daily cost of an
        intensive care unit day: The contribution of mechanical ventilation.
        Critical Care Medicine, 2005; 33(6):1266-1271

'/>"/>
SOURCE Hospira, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Ovation further advances development pipeline with new phase III epilepsy study
2. AKELA Pharma Inc. announces positive results for the extension part of its Phase IIb Fentanyl TAIFUN(R) trial
3. Mannatech Launches Phase One of New Sales and Training Tools
4. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
5. Manic phase of bipolar disorder benefits from breast cancer medication
6. ARIZONA METH PROJECT Unveils Arizonas Anti-Meth Youth Pledge and Kicks Off Phase Two of Public Awareness Campaign
7. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
8. Alexza to Initiate the First Phase 3 Trial for AZ-004 (Staccato(R) Loxapine) in Late Q1 2008
9. Iomai Patch-Based Vaccine Cut Rate of Travelers Diarrhea by 75 Percent in Phase 2 Field Study
10. MetLife Foundation Begins New Phase of Award-Winning Parenting Skills Campaign in Collaboration with the Partnership for a Drug-Free America(R)
11. Labopharm completes enrolment for Phase III clinical study for its once-daily trazodone antidepressant drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... These vanadium reserves are mostly found in ... tons of vanadium were produced globally in 2013, up ... at 6.7% AAGR during the period from 2001 to ... the largest consumer, accounted for more than 90% of ... and the chemical industry. , View Full Report at ...
(Date:12/19/2014)... FRIDAY, Dec. 19, 2014 (HealthDay News) -- New research warns parents ... young lives at risk. Nearly half of teen drivers killed ... that were at least 11 years old and often lacked important ... Eighty-two percent of teen drivers killed in crashes were in ... six to 10 years old, 31 percent were in cars 11 ...
(Date:12/19/2014)... FRIDAY, Dec. 19, 2014 (HealthDay News) -- Injectable drug ... double the suicide attempt rate of other substance users, ... use is associated with the risk of suicide attempt ... the University of Montreal, said in a university news ... users. We wanted to know who among substance users ...
(Date:12/19/2014)... Raleigh, NC (PRWEB) December 19, 2014 Surviving ... asbestos and EPA information indicates that these pipes can leach ... to go to the full story on the Surviving ... to the erosion of natural asbestos deposits, decaying water mains ... in drinking water. , To protect consumers from ...
(Date:12/19/2014)... B. E. Smith, the only full-service leadership solutions ... to lead a national chief financial officer search ... top executive search firm in the healthcare industry, B. ... executives into organizations. , Johnson Memorial Hospital is ... the residents of Johnson County and the surrounding areas. ...
Breaking Medicine News(10 mins):Health News:Marketresearchreports.biz: Global Vanadium Usage Increased at AAGR of 6.7% between 2001 and 2013 2Health News:Marketresearchreports.biz: Global Vanadium Usage Increased at AAGR of 6.7% between 2001 and 2013 3Health News:Older Cars a Bad Choice for Younger Drivers 2Health News:Cocaine, Amphetamines May Up Injection Drug Users' Suicide Risk 2Health News:Surviving Mesothelioma Warns of Potential Mesothelioma Risk from Cement Water Pipes 2Health News:Johnson Memorial Hospital Retains B. E. Smith to Recruit New Chief Financial Officer 2Health News:Johnson Memorial Hospital Retains B. E. Smith to Recruit New Chief Financial Officer 3
... on knowing when you,re ready to drive again , , WEDNESDAY, ... get behind the wheel again after orthopedic surgery or injury, but ... turning the key. , Orthopedic surgeons weigh in on the issue ... Joint Surgery . , "Deciding when a patient can return ...
... (OTC Pink Sheets: SNDY ) is pleased to announce that ... by over 10% compared to the same time period for 2007. ... $28,509 for the same month last year. This marks the second ... of October. , , The Mammo ...
... Dec. 10 GeneGo, Inc., a leading,provider of software ... ,today announced that A*STAR,s Singapore Immunology Network (SIgN) has ... will have access,to GeneGo,s MetaCore, training and advanced support. ... all SIgN researchers. , ...
... Three Skilled Nursing Facilities , , ... intense 18-month selection process, a proven commitment to clinical ... records (EMR) throughout Metropolitan Jewish Health System,s (Metropolitan) skilled ... Metropolitan, a nationally recognized nonprofit organization, operates Metropolitan ...
... Services, Goodwill, , , ... MDZ ), a leading provider of products and services ... 2008 performance. , Based on preliminary information, MDS expects ... $1,210 million to $1,220 million and adjusted EBITDA in the range ...
... While They,re Still Healthy Enough to Qualify , ... you,ve put off getting long term care insurance, should you ... health plan? "I wouldn,t advise it," says Denise Gott, Chairman ... of the nation,s most experienced long term care insurance agencies. ...
Cached Medicine News:Health News:Returning to the Road Tricky After Injury 2Health News:Solos Endoscopy, Inc. Increases Sales Revenue for October 2008 by Over 10% as Compared to Last Year 2Health News:A*STAR's Singapore Immunology Network Is the First GeneGo Center of Excellence in Asia 2Health News:Metropolitan Jewish Health System Awards Electronic Medical Records Contract to SigmaCare(R) 2Health News:Metropolitan Jewish Health System Awards Electronic Medical Records Contract to SigmaCare(R) 3Health News:MDS Provides Update on Fiscal 2008 Performance 2Health News:MDS Provides Update on Fiscal 2008 Performance 3Health News:MDS Provides Update on Fiscal 2008 Performance 4Health News:Obama Health Plan Not Likely to Embrace Long Term Care, Industry Leader Says 2
(Date:12/19/2014)... --Research and Markets ( http://www.researchandmarkets.com/research/942kh3/micro_market ) ... Market Monitor: North American Dermatology Diagnostic Devices Market" ... http://photos.prnewswire.com/prnh/20130307/600769 Cosmetic surgeries ... resulted in fueling the overall demand of the ... these dermatology devices is to assist in identifying ...
(Date:12/19/2014)... , Dec. 18, 2014  Decision Resources Group ... the United States will increase to a ... be primarily driven by expansion in the large direct ... devices will be increasingly adopted due to the advantages ... Other key findings from Decision Resources Group,s coverage ...
(Date:12/19/2014)... , Dec. 18, 2014  RESMED INC. (NYSE: ... second quarter of fiscal year 2015 results on Thursday, January ... A press release with ResMed,s results will be issued after ... a webcast to discuss operating results and future outlook. ... p.m. US Pacific Time and the live webcast of the ...
Breaking Medicine Technology:Micro Market Monitor: North American Dermatology Diagnostic Devices Market 2Micro Market Monitor: North American Dermatology Diagnostic Devices Market 3U.S. Laparoscopic Device Market Will Reach Over $4.3 Billion by 2023 2U.S. Laparoscopic Device Market Will Reach Over $4.3 Billion by 2023 3ResMed To Announce Second Quarter 2015 Results 2
... Index (BMI) Rebound Age, Can Predict Heart Disease and Calls for ... Children,s ... The results from the newest study,in a continuum of research on childhood ... reason for pediatricians to begin,measuring and monitoring body mass index (BMI) in ...
... Tissue Oncology, Society held in Seattle, Washington demonstrates clinical ... single agent in patients with ... chemo-insensitive sarcomas, NEW YORK, Nov. ... preliminary data demonstrating the,tolerability and clinical activity of KRX-0401 (perifosine) in ...
Cached Medicine Technology:New Risk Factor for Heart Disease Identified in Very Young Children, According to Study at American Heart Association Scientific Sessions 2New Risk Factor for Heart Disease Identified in Very Young Children, According to Study at American Heart Association Scientific Sessions 3Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma 2Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma 3Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma 4Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma 5Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma 6
Housed in a small lightweight, flame retardant plastic cases, meters are equipped with a convenient multiposition handle/stand. Measure microcirculation in 1 cubic mm of tissue for real-time assessme...
... Strips are non-invasive and theres no expensive ... Perfusion Monitor Strips are simple to use. ... reliable. The advanced liquid crystal technology has ... range of applications including biofeedback, nerve blocks, ...
... a high performance laser doppler system ... (tissue) blood perfusion. This latest generation ... introduced with its multi-channel brother (Oxyflo), ... processing and laser doppler flowmetry providing ...
Transcranial vascular DWL doppler....
Medicine Products: